AAN Practice Guideline: Disease-Modifying Therapies for Adults With Multiple Sclerosis

This clinical guideline provides evidence-based recommendations for healthcare professionals. It was developed by American Academy of Neurology through systematic review of available evidence and expert consensus.

Document Details

• Issuing Authority: American Academy of Neurology
• Type: Clinical Guideline
• Specialty Area: Neurology & Neurosurgery
• Date: 2018

Access the Full Guideline

View Full Guideline →

Source: American Academy of Neurology. This content is provided for informational purposes. Always refer to the official document for the most current version and recommendations.